Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

Critical Care

Volumn 12, Issue 1, 2008, Pages

  Bopp, Christian ^a   Bierhaus, Angelika ^a   Hofer, Stefan ^a   Bouchon, Axel ^b   Nawroth, Peter P ^a   Martin, Eike ^a   Weigand, Markus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BAYER CROPSCIENCE AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN S 100; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

CELL ACTIVATION; DRUG TARGETING; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SURVIVAL; SURVIVAL RATE; WILD TYPE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; RECEPTORS, IMMUNOLOGIC; SEPSIS; SIGNAL TRANSDUCTION;

EID: 45549107924     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6164     Document Type: Review

References (81)

1. Weigand MA Horner C Bardenheuer HJ Bouchon A The systemic inflammatory response syndrome Best Pract Res Clin Anaesthesiol 2004, 18:455-475. 10.1016/j.bpa.2003.12.005 15212339
2. Martin GS Mannino DM Eaton S Moss M The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139 12700374
3. Aderem A Ulevitch RJ Toll-like receptors in the induction of the innate immune response Nature 2000, 406:782-787. 10.1038/35021228 10963608
4. Vely F Vivier E Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts J Immunol 1997, 159:2075-2077. 9278290
5. Colonna M TREMs in the immune system and beyond Nat Rev Immunol 2003, 3:445-453. 10.1038/nri1106 12776204
6. Wang H Bloom O Zhang M Vishnubhakat JM Ombrellino M Che J Frazier A Yang H Ivanova S Borovikova L et al.: HMGB-1 as a late mediator of endotoxin lethality in mice Science 1999, 285:248-251. 10.1126/ science.285.5425.248 10398600
7. Riedemann NC Guo RF Ward PA Novel strategies for the treatment of sepsis Nat Med 2003, 9:517-524. 10.1038/nm0503-517 12724763
8. Lisanti MP Scherer PE Vidugiriene J Tang Z Hermanowski-Vosatka A Tu YH Cook RF Sargiacomo M et al.: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease J Cell Biol 1994, 126:111-126. 10.1083/jcb.126.1.111 7517942
9. Neeper M Schmidt AM Brett J Yan SD Wang F Pan YC Elliston K Stern D Shaw A Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 1992, 267:14998-15004. 1378843
10. Schmidt AM Vianna M Gerlach M Brett J Ryan J Kao J Esposito C Hegarty H Hurley W Clauss M et al.: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 1992, 267:14987-14997. 1321822
11. Shirasawa M Fujiwara N Hirabayashi S Ohno H Iida J Makita K Hata Y Receptor for advanced glycation end-products is a marker of type I lung alveolar cells Genes Cells 2004, 9:165-174. 10.1111/ j.1356-9597.2004.00712.x 15009093
12. Katsuoka F Kawakami Y Arai T Imuta H Fujiwara M Kanma H Yamashita K Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene Biochem Biophys Res Commun 1997, 238:512-516. 10.1006/bbrc.1997.7263 9299542
13. Schlueter C Hauke S Flohr AM Rogalla P Bullerdiek J Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim Biophys Acta 2003, 1630:1-6. 14580673
14. Bierhaus A Humpert PM Morcos M Wendt T Chavakis T Arnold B Stern DM Nawroth PP Understanding RAGE, the receptor for advanced glycation end products J Mol Med 2005, 83:876-886. 10.1007/s00109-005-0688-7 16133426
15. Brett J Schmidt AM Yan SD Zou YS Weidman E Pinsky D Nowygrod R Neeper M Przysiecki C Shaw A et al.: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 1993, 143:1699-1712. 1887265 8256857
16. Huttunen HJ Fages C Rauvala H Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 1999, 274:19919-19924. 10.1074/ jbc.274.28.19919 10391939
17. Thornalley PJ Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors Chem Biol Interact 1998, 111:137-151. 10.1016/S0009-2797(97)00157-9 9679550
18. Bierhaus A Schiekofer S Schwaninger M Andrassy M Humpert PM Chen J Hong M Luther T Henle T Kloting I et al.: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB Diabetes 2001, 50:2792-2808. 10.2337/diabetes.50.12.2792 11723063
19. Sousa MM Yan SD Stern D Saraiva MJ Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation Lab Invest 2000, 80:1101-1110. 10908156
20. Degryse B Bonaldi T Scaffidi P Muller S Resnati M Sanvito F Arrigoni G Bianchi ME The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 2001, 152:1197-1206. 10.1083/jcb.152.6.1197 11257120
21. Chavakis T Bierhaus A Nawroth PP RAGE (receptor for advanced glycation end products): A central player in the inflammatory response Microbes Infect 2004, 6:1219-1225. 10.1016/j.micinf.2004.08.004 15488742
22. Li J Schmidt AM Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J Biol Chem 1997, 272:16498-16506. 10.1074/jbc.272.26.16498 9195959
23. Takada M Hirata K Ajiki T Suzuki Y Kuroda Y Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells Hepatogastroenterology 2004, 51:928-930. 15239215
24. Malherbe P Richards JG Gaillard H Thompson A Diener C Schuler A Huber G cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein Brain Res Mol Brain Res 1999, 71:159-170. 10.1016/S0169-328X(99)00174-6 10521570
25. Sugaya K Fukagawa T Matsumoto K Mita K Takahashi E Ando A Inoko H Ikemura T Three genes in the human MHC class III region near the junction with the class II: Gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3 Genomics 1994, 23:408-419. 10.1006/ geno.1994.1517 7835890
26. Hofmann MA Drury S Fu C Qu W Taguchi A Lu Y Avila C Kambham N Bierhaus A Nawroth P et al.: RAGE mediates a noveA proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 1999, 97:889-901. 10.1016/S0092-8674(00)80801-6 10399917
27. Ishihara K Tsutsumi K Kawane S Nakajima M Kasaoka T The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site FEBS Lett 2003, 550:107-113. 10.1016/ S0014-5793(03)00846-9 12935895
28. Hanford LE Enghild JJ Valnickova Z Petersen SV Schaefer LM Schaefer TM Reinhart TA Oury TD Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) J Biol Chem 2004, 279:50019-50024. 1868562 15381690 10.1074/jbc.M409782200
29. Simm A Bartling B Silber RE RAGE: A new pleiotropic antagonistic gene? Ann N Y Acad Sci 2004, 1019:228-231. 10.1196/annals.1297.038 15247020
30. Hori O Brett J Slattery T Cao R Zhang J Chen JX Nagashima M Lundh ER Vijay S Nitecki D et al.: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 1995, 270:25752-25761. 10.1074/ jbc.270.43.25752 7592757
31. Du Yan S Zhu H Fu J Yan SF Roher A Tourtellotte WW Rajavashisth T Chen X Godman GC Stern D et al.: Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease Proc Natl Acad Sci U S A 1997, 94:5296-5301. 24672 9144231 10.1073/pnas.94.10.5296
32. Yan SD Zhu H Zhu A Golabek A Du H Roher A Yu J Soto C Schmidt AM Stern D et al.: Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat Med 2000, 6:643-651. 10.1038/76216 10835680
33. Chavakis T Bierhaus A Al-Fakhri N Schneider D Witte S Linn T Nagashima M Morser J Arnold B Preissner KT et al.: The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment J Exp Med 2003, 198:1507-1515. 10.1084/ jem.20030800 14623906 2194124
34. Sasaki N Takeuchi M Chowei H Kikuchi S Hayashi Y Nakano N Ikeda H Yamagishi S Kitamoto T Saito T et al.: Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques Neurosci Lett 2002, 326:117-120. 10.1016/S0304-3940(02)00310-5 12057842
35. Chapman MR Robinson LS Pinkner JS Roth R Heuser J Hammar M Normark S Hultgren SJ Role of Escherichia coli curli operons in directing amyloid fiber formation Science 2002, 295:851-855. 10.1126/science.1067484 11823641
36. Kislinger T Fu C Huber B Qu W Taguchi A Du Yan S Hofmann M Yan SF Pischetsrieder M Stern D et al.: N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J Biol Chem 1999, 274:31740-31749. 10.1074/jbc.274.44.31740 10531386
37. Anderson MM Requena JR Crowley JR Thorpe SR Heinecke JW The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation J Clin Invest 1999, 104:103-113. 408396 10393704 10.1172/JCI3042
38. Thornalley PJ Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs Cell Mol Biol (Noisy-le-grand) 1998, 44:1013-1023. 9846883
39. Lander HM Tauras JM Ogiste JS Hori O Moss RA Schmidt AM Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 1997, 272:17810-17814. 10.1074/ jbc.272.28.17810 9211935
40. Wautier MP Chappey O Corda S Stern DM Schmidt AM Wautier JL Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE Am J Physiol Endocrinol Metab 2001, 280:E685-694. 11287350
41. Bierhaus A Chevion S Chevion M Hofmann M Quehenberger P Illmer T Luther T Berentshtein E Tritschler H Muller M Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells Diabetes 1997, 46:1481-1490. 10.2337/ diabetes.46.9.1481 9287050
42. Sorci G Riuzzi F Arcuri C Giambanco I Donato R Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding Mol Cell Biol 2004, 24:4880-4894. 416409 15143181 10.1128/MCB.24.11.4880-4894.2004
43. Taguchi A Blood DC del Toro G Canet A Lee DC Qu W Tanji N Lu Y Lalla E Fu C et al.: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 2000, 405:354-360. 10.1038/35012626 10830965
44. Huang JS Guh JY Chen HC Hung WC Lai YH Chuang LY Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells J Cell Biochem 2001, 81:102-113. 10.1002/ 1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y 11180401
45. Marenholz I Heizmann CW Fritz G S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature) Biochem Biophys Res Commun 2004, 322:1111-1122. 10.1016/ j.bbrc.2004.07.096 15336958
46. Donato R S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Int J Biochem Cell Biol 2001, 33:637-668. 10.1016/S1357-2725(01)00046-2 11390274
47. Schafer BW Heinzmann CW The S100 family of EF-hand calcium-binding proteins: Functions and pathology Trends Biochem Sci 1996, 21:134-140. 8701470
48. Yan SSD Wu ZY Zhang HP Furtado G Chen X Yan SF Schmidt AM Brown C Stern A LaFaille J et al.: Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat Med 2003, 9:287-293. 10.1038/nm831 12598893
49. Arumugam T Simeone DM Schmidt AM Logsdon CD S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) J Biol Chem 2004, 279:5059-5065. 10.1074/jbc.M310124200 14617629
50. Huttunen HJ Kuja-Panula J Sorci G Agneletti AL Donato R Rauvala H Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation J Biol Chem 2000, 275:40096-40105. 10.1074/ jbc.M006993200 11007787
51. Weigand MA Volkmann M Schmidt H Martin E Bohrer H Bardenheuer HJ Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock Anesthesiology 2000, 92:905-907. 10.1097/ 00000542-200003000-00057 10719986
52. Lotze MT Tracey KJ High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal Nat Rev Immunol 2005, 5:331-342. 10.1038/ nri1594 15803152
53. Rauvala H Pihlaskari R Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons J Biol Chem 1987, 262:16625-16635. 3680268
54. Rauvala H Merenmies J Pihlaskari R Korkolainen M Huhtala ML Panula P The adhesive and neurite-promoting molecule p30: Analysis of the amino terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons J Cell Biol 1988, 107:2293-2305. 10.1083/jcb.107.6.2293 2461949
55. Dumitriu IE Baruah P Valentinis B Voll RE Herrmann M Nawroth PP Arnold B Bianchi ME Manfredi AA Rovere-Querini P Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 2005, 174:7506-7515. 15944249
56. Bonaldi T Talamo F Scaffidi P Ferrera D Porto A Bachi A Rubartelli A Agresti A Bianchi ME Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO J 2003, 22:5551-5560. 213771 14532127 10.1093/emboj/cdg516
57. Asea A Rehli M Kabingu E Boch JA Bare O Auron PE Stevenson MA Calderwood SK Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4 J Biol Chem 2002, 277:15028-15034. 10.1074/jbc.M200497200 11836257
58. Schnurr M Toy T Stoitzner P Cameron P Shin A Beecroft T Davis ID Cebon J Maraskovsky E ATP gradients inhibit the migratory capacity of specific human dendritic cell types: Implications for P2Y11 receptor signaling Blood 2003, 102:613-620. 10.1182/blood-2002-12-3745 12649135
59. Shi Y Evans JE Rock KL Molecular identification of a danger signal that alerts the immune system to dying cells Nature 2003, 425:516-521. 10.1038/nature01991 14520412
60. Scaffidi P Misteli T Bianchi ME Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 2002, 418:191-195. 10.1038/ nature00858 12110890
61. Huttunen HJ Fages C Kuja-Panula J Ridley AJ Rauvala H Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res 2002, 62:4805-4811. 12183440
62. Andersson U Wang H Palmblad K Aveberger AC Bloom O Erlandsson-Harris H Janson A Kokkola R Zhang M Yang H et al.: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 2000, 192:565-570. 10.1084/jem.192.4.565 10952726 2193240
63. Abeyama K Stern DM Ito Y Kawahara K Yoshimoto Y Tanaka M Uchimura T Ida N Yamazaki Y Yamada S et al.: The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism J Clin Invest 2005, 115:1267-1274. 1077171 15841214 10.1172/ JCI200522782
64. Wang H Yang H Czura CJ Sama AE Tracey KJ HMGB1 as a late mediator of lethal systemic inflammation Am J Respir Crit Care Med 2001, 164:1768-1773. 11734424
65. Rouhiainen A Kuja-Panula J Wilkman E Pakkanen J Stenfors J Tuominen RK Lepantalo M Carpen O Parkkinen J Rauvala H Regulation of monocyte migration by amphoterin (HMGB1) Blood 2004, 104:1174-1182. 10.1182/ blood-2003-10-3536 15130941
66. Sappington PL Yang R Yang H Tracey KJ Delude RL Fink MP HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice Gastroenterology 2002, 123:790-802. 10.1053/gast.2002.35391 12198705
67. Kokkola R Andersson A Mullins G Ostberg T Treutiger CJ Arnold B Nawroth P Andersson U Harris RA Harris HE RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 2005, 61:1-9. 10.1111/j.0300-9475.2005.01534.x 15644117
68. Park JS Svetkauskaite D He Q Kim JY Strassheim D Ishizaka A Abraham E Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 2004, 279:7370-7377. 10.1074/jbc.M306793200 14660645
69. Yu M Wang H Ding A Golenbock DT Latz E Czura CJ Fenton MJ Tracey KJ Yang H HMGB1 signals through toll-like receptor (TLR) 4 and TLR2 Shock 2006, 26:174-179. 10.1097/01.shk.0000225404.51320.82 16878026
70. Tsung A Sahai R Tanaka H Nakao A Fink MP Lotze MT Yang H Li J Tracey KJ Geller DA et al.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 2005, 201:1135-1143. 10.1084/ jem.20042614 15795240 2213120
71. Abraham E Arcaroli J Carmody A Wang H Tracey KJ HMG-1 as a mediator of acute lung inflammation J Immunol 2000, 165:2950-2954. 10975801
72. Ueno H Matsuda T Hashimoto S Amaya F Kitamura Y Tanaka M Kobayashi A Maruyama I Yamada S Hasegawa N et al.: Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 2004, 170:1310-1316. 10.1164/rccm.200402-188OC 15374839
73. Yang H Ochani M Li J Qiang X Tanovic M Harris HE Susarla SM Ulloa L Wang H DiRaimo R et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci U S A 2004, 101:296-301. 314179 14695889 10.1073/pnas.2434651100
74. Wang H Liao H Ochani M Justiniani M Lin X Yang L Al-Abed Y Wang H Metz C Miller EJ et al.: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat Med 2004, 10:1216-1221. 10.1038/ nm1124 15502843
75. Liliensiek B Weigand MA Bierhaus A Nicklas W Kasper M Hofer S Plachky J Grone HJ Kurschus FC Schmidt AM et al.: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 2004, 113:1641-1650. 419481 15173891 10.1172/ JCI200418704
76. Zeng S Feirt N Goldstein M Guarrera J Ippagunta N Ekong U Dun H Lu Y Qu W Schmidt AM et al.: Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice Hepatology 2004, 39:422-432. 10.1002/hep.20045 14767995
77. Cataldegirmen G Zeng S Feirt N Ippagunta N Dun H Qu W Lu Y Rong LL Hofmann MA Kislinger T et al.: RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB J Exp Med 2005, 201:473-484. 10.1084/jem.20040934 15699076 2213026
78. Hou FF Ren H Owen WF Jr Guo ZJ Chen PY Schmidt AM Miyata T Zhang X Enhanced expression of receptor for advanced glycation end products in chronic kidney disease J Am Soc Nephrol 2004, 15:1889-1896. 10.1097/ 01.ASN.0000131526.99506.F7 15213278
79. BI Stickland MH Grant PJ Futers TS Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5′ regulatory region on chromosome 3: Implications for polymorphic studies in diabetes Diabetes 2001, 50:2646-2651. 10.2337/diabetes.50.12.2646 11723045
80. Kankova K Marova I Zahejsky J Muzik J Stejskalova A Znojil V Vacha J Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status Metabolism 2001, 50:1152-1160. 10.1053/ meta.2001.26757 11586486
81. Hofmann MA Drury S Hudson BI Gleason MR Qu W Lu Y Lalla E Chitnis S Monteiro J StiTkland MH et al.: RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response Genes Immun 2002, 3:123-135. 10.1038/sj.gene.6363861 12070776